Oxyphenbutazone
Generic Name: oxyphenbutazone
Manufactured by WATSON LABS. Dosage form: TABLET. Route: ORAL. Active ingredients: OXYPHENBUTAZONE (100MG). Application: ANDA088399.
Overview
Manufactured by WATSON LABS. Dosage form: TABLET. Route: ORAL. Active ingredients: OXYPHENBUTAZONE (100MG). Application: ANDA088399.
Dosage
Available as tablet for oral use.
Related Medications
Berb. Vulgd3, Carduus Md2, Chelidoniumd2, Cholestrinumd3, Hydrastisd3, Ptelead3
berb. vulgd3, carduus md2, chelidoniumd2, cholestrinumd3, hydrastisd3, ptelead3
Temporarily relieves discomfort due to yellow skin and eyes, flatulence, bitter taste, difficulty passing stool, and swelling of the liver and abdomen with a sensation of pressure.* *Claims Based on Traditional Homeopathic Practice, Not Accepted Medical Evidence, Not FDA Evaluated. This product is not intended to diagnose, treat, cure, or prevent any disease.
Talquetamab
talquetamab
11 DESCRIPTION Talquetamab-tgvs is a bispecific GPRC5D-directed CD3 T-cell engager. It is a humanized IgG4 proline, alanine, alanine (IgG4-PAA)-based bispecific antibody produced by Chinese hamster ovary (CHO) cells using recombinant DNA technology. Talquetamab-tgvs consists of an anti-GPRC5D heavy chain and light chain and an anti-CD3 heavy chain and light chain with two interchain disulfide bonds connecting the two arms. The molecular weight of talquetamab-tgvs is 147 kDa.
Acetaminophen, Dextromethorphan Hbr, Doxylamine Succinate
acetaminophen, dextromethorphan hbr, doxylamine succinate
Uses temporarily relieves common cold/flu symptoms minor aches and pains headache sore throat fever runny nose and sneezing cough due to minor throat and bronchial irritation
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.